ARTICLE | Company News
Purdue Pharma sales and marketing update
February 2, 2015 8:00 AM UTC
Purdue launched Hysingla ER in the U.S. to manage long-term severe pain. Hysingla is a once-daily, extended-release (ER) formulation of hydrocodone bitartrate formulated with an abuse-deterrent techn...